Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$84.3 - $94.31 $82 Million - $91.7 Million
972,733 Added 134.42%
1,696,383 $157 Million
Q1 2024

May 13, 2024

BUY
$72.54 - $95.56 $52.5 Million - $69.2 Million
723,650 New
723,650 $69.2 Million
Q3 2022

Nov 10, 2022

BUY
$82.37 - $107.29 $78.5 Million - $102 Million
952,754 New
952,754 $78.7 Million
Q1 2020

May 12, 2020

SELL
$52.41 - $81.0 $26.1 Million - $40.4 Million
-498,193 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$71.7 - $82.09 $6.04 Million - $6.92 Million
-84,303 Reduced 14.47%
498,193 $116 Million
Q3 2019

Nov 12, 2019

SELL
$61.55 - $75.43 $1.33 Million - $1.63 Million
-21,617 Reduced 3.58%
582,496 $128 Million
Q2 2019

Aug 09, 2019

SELL
$55.74 - $64.41 $4.41 Million - $5.09 Million
-79,079 Reduced 11.57%
604,113 $112 Million
Q1 2019

May 10, 2019

SELL
$47.89 - $64.05 $18.6 Million - $24.9 Million
-388,072 Reduced 36.23%
683,192 $131 Million
Q4 2018

Feb 12, 2019

SELL
$46.41 - $56.94 $28.8 Million - $35.4 Million
-621,534 Reduced 36.72%
1,071,264 $164 Million
Q3 2018

Nov 13, 2018

SELL
$45.7 - $58.03 $4.09 Million - $5.19 Million
-89,448 Reduced 5.02%
1,692,798 $295 Million
Q2 2018

Aug 10, 2018

SELL
$42.45 - $51.3 $4.71 Million - $5.7 Million
-111,020 Reduced 5.86%
1,782,246 $259 Million
Q1 2018

May 10, 2018

SELL
$37.19 - $47.45 $2.38 Million - $3.04 Million
-64,077 Reduced 3.27%
1,893,266 $264 Million
Q4 2017

Feb 12, 2018

BUY
$33.79 - $39.39 $17.7 Million - $20.7 Million
524,915 Added 36.65%
1,957,343 $221 Million
Q3 2017

Nov 13, 2017

BUY
$36.29 - $38.83 $52 Million - $55.6 Million
1,432,428
1,432,428 $157 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.